The findings indicated that TNF-α inhibitors more effectively reduced coronary inflammation, evidenced by significant reductions in CIMT, coronary plaques (measured by CCTA), CRP, and Psoriasis Area and Severity Index (PASI) scores compared to phototherapy [16, 32]. The gene discussed is TNF; the disease is psoriasis.